Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 3/20 | 0.50 |
| ▸ | SNCA | P37840 | 3/20 | 0.46 |
| ▸ | BCHE | P06276 | 7/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29850631 | 1.00 | NOX1 (0.50) | NOX1SNCABCHEMAPTGAA | |
| SCHEMBL30851251 | 0.83 | NOX1 (0.54) | NOX1SNCABCHEKDM4E | |
| SCHEMBL1926804 | 0.83 | NOX1 (0.54) | NOX1SNCABCHEKDM4E | |
| SCHEMBL10847578 | 0.81 | NOX1 (0.53) | NOX1SNCAMAPTPOLBKDM4E | |
| SCHEMBL8223437 | 0.75 | NOX1 (0.46) | NOX1SNCABCHE | |
| SCHEMBL19942820 | 0.74 | BCHE (0.49) | SNCABCHEMAPTGAANPSR1 | |
| SCHEMBL5452710 | 0.74 | SNCA (0.73) | NOX1SNCABCHEGAAPOLB | |
| SCHEMBL29776881 | 0.74 | SNCA (0.73) | NOX1SNCABCHEGAAPOLB | |
| SCHEMBL1208719 | 0.73 | NOX1 (0.50) | NOX1SNCABCHEMAPTPOLB | |
| SCHEMBL29850616 | 0.73 | NOX1 (0.50) | NOX1SNCABCHEMAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250325557-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2025-10-23 | — | — | US | disclosed |
| US-12324810-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | WISTA LABORATORIES LTD. (SG) | 2025-06-10 | — | — | US | disclosed |
| US-20240245700-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2024-07-25 | — | — | US | disclosed |
| US-11951110-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | WISTA LABORATORIES LTD. (SG) | 2024-04-09 | — | — | US | disclosed |
| CN-109384741-B | 3,7-diamino-10H-phenothiazine compound salt and application thereof | 维斯塔实验室有限公司 | 2023-01-06 | — | — | CN | disclosed |
| CN-104606199-B | 3, 7-diamino-10H-phenothiazine compound salt and use thereof | 维斯塔实验室有限公司 | 2022-09-13 | — | — | CN | disclosed |
| US-11344558-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | WISTA LABORATORIES LTD. (SG) | 2022-05-31 | — | — | US | disclosed |
| US-20220152038-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2022-05-19 | — | — | US | disclosed |
| US-20190151329-A1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | WISTA LABORATORIES LTD. (SG) | 2019-05-23 | — | — | US | disclosed |
| US-10188658-B2 | Therapeutic use of diaminophenothiazines | WISTA LABORATORIES LTD. (SG) | 2019-01-29 | — | — | US | disclosed |
| US-8710051-B2 | 3,7-diamino-10H-phenothiazine salts and their use | Wis Ta Laboratories Ltd. (SG) | 2014-04-29 | — | — | US | disclosed |
| US-20110118242-A1 | 3,7-DIAMINO-10H-PHINOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. | 2011-05-19 | — | — | US | disclosed |
| US-7888350-B2 | 3,7-diamino-10H-phenothiazine salts and their use | WISTA LABORATORIES LTD. (SG) | 2011-02-15 | — | — | US | disclosed |
| US-20100290986-A1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | Wis Ta Laboratories Ltd. | 2010-11-18 | — | — | US | disclosed |
| EP-2013191-B1 | 3,7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LAB LTD (SG) | 2010-08-18 | — | — | EP | disclosed |
| EP-2205245-A1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | Wista Laboratories Ltd. (SG) | 2010-07-14 | — | — | EP | disclosed |
| WO-2009044127-A1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | WISTA LABORATORIES LTD. (GB) | 2009-04-09 | — | — | WO | disclosed |
| US-20090054419-A1 | 3,7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. | 2009-02-26 | — | — | US | disclosed |
| EP-2013191-A2 | 3,7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | Wista Laboratories Ltd. (SG) | 2009-01-14 | — | — | EP | disclosed |
| WO-2007110627-A2 | 3,7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2007-10-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325557-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | NOX1 187/4885SNCA 673/4885BCHE 468/4885 |
| US-12324810-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | PSEN1, PSEN2, APP | NOX1 347/4885SNCA 467/4885BCHE 460/4885 |
| US-20110118242-A1 | 3,7-DIAMINO-10H-PHINOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | NOX1 450/4885SNCA 1937/4885BCHE 260/4885 |
| US-20100290986-A1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | QDPR, DDO, HNMT | NOX1 2161/4885SNCA 447/4885BCHE 68/4885 |
| US-11951110-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | PSEN1, PSEN2, APP | NOX1 187/4885SNCA 673/4885BCHE 468/4885 |
| US-10188658-B2 | Therapeutic use of diaminophenothiazines | QDPR, DDO, HNMT | NOX1 2397/4885SNCA 430/4885BCHE 72/4885 |
| US-11344558-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | PSEN1, PSEN2, APP | NOX1 187/4885SNCA 673/4885BCHE 468/4885 |
| US-20220152038-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | NOX1 255/4885SNCA 437/4885BCHE 350/4885 |
| US-20190151329-A1 | THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES | QDPR, DDO, HNMT | NOX1 2264/4885SNCA 398/4885BCHE 66/4885 |
| US-20240245700-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | NOX1 347/4885SNCA 467/4885BCHE 460/4885 |
| US-20090054419-A1 | 3,7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, HTT | NOX1 490/4885SNCA 1049/4885BCHE 170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.